
The appointment comes as bankers worldwide anticipate a rebound in dealmaking in the second half of the year despite tariff disputes and regulatory hurdles.
Analysts expect 2026 to be a bumper year for investment banking as easing rates, recovering markets and renewed corporate confidence fuel a pickup in mergers and capital raising.
Lee will start at the largest U.S. bank by assets in the first quarter of next year, after 19 years at rival Goldman Sachs.
He recently served as Goldman's global head of biopharma banking and healthcare investment banking services.
Investment banking remains a key profit-driver for lenders, with fees from advising on mergers and underwriting capital raises often among their most lucrative revenue streams during periods of strong deal activity.
Lee, who was promoted to partner at Goldman in 2020, has advised on more than $300 billion worth of announced mergers and acquisitions, the memo said.
(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.)
Subscribe to The Economic Times Prime and read the ET ePaper online.
(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.)
Subscribe to The Economic Times Prime and read the ET ePaper online.